MedPath

Serum Free Light Change in Multiple Myeloma

Completed
Conditions
Multiple Myeloma
Registration Number
NCT00910078
Lead Sponsor
Azienda Ospedaliera San Giovanni Battista
Brief Summary

The purpose of this study is to evaluate the predictive role of free Kappa/Lambda ration in Multiple Myeloma post-transplant.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Patients affected with Multiple Myeloma who underwent autologous or auto/allogenic stem cell transplantation.
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Azienda Ospedaliera S. Giovanni Battista

🇮🇹

Torino, Italy

© Copyright 2025. All Rights Reserved by MedPath